000179569 001__ 179569
000179569 005__ 20240229145547.0
000179569 0247_ $$2doi$$a10.1007/s00134-022-06676-3
000179569 0247_ $$2pmid$$apmid:35429256
000179569 0247_ $$2pmc$$apmc:PMC9012907
000179569 0247_ $$2ISSN$$a0340-0964
000179569 0247_ $$2ISSN$$a0342-4642
000179569 0247_ $$2ISSN$$a0935-1701
000179569 0247_ $$2ISSN$$a1432-1238
000179569 0247_ $$2altmetric$$aaltmetric:126726932
000179569 037__ $$aDKFZ-2022-00747
000179569 041__ $$aEnglish
000179569 082__ $$a610
000179569 1001_ $$aKorell, Felix$$b0
000179569 245__ $$aPre-transplant EASIX and sepsis after allogeneic stem cell transplantation.
000179569 260__ $$aBerlin$$bSpringer$$c2022
000179569 3367_ $$2DRIVER$$aarticle
000179569 3367_ $$2DataCite$$aOutput Types/Journal article
000179569 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1655905601_23455$$xLetter
000179569 3367_ $$2BibTeX$$aARTICLE
000179569 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000179569 3367_ $$00$$2EndNote$$aJournal Article
000179569 500__ $$a#LA:C060# / 2022 Jun;48(6):753-755
000179569 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000179569 542__ $$2Crossref$$i2022-04-16$$uhttps://creativecommons.org/licenses/by-nc/4.0
000179569 542__ $$2Crossref$$i2022-04-16$$uhttps://creativecommons.org/licenses/by-nc/4.0
000179569 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000179569 7001_ $$0P:(DE-He78)0d054b6843ace36d1c965b6cb938d1c9$$aSchreck, Nicholas$$b1$$udkfz
000179569 7001_ $$aMüller-Tidow, Carsten$$b2
000179569 7001_ $$aDreger, Peter$$b3
000179569 7001_ $$00000-0002-0387-1640$$aLuft, Thomas$$b4
000179569 7001_ $$aTaskforce allogeneic Stem Cell Transplantation, University Hospital Heidelberg$$b5$$eCollaboration Author
000179569 7001_ $$aLiebregts, Tobias$$b6
000179569 7001_ $$aSchönland, Stefan$$b7
000179569 7001_ $$aHegenbart, Ute$$b8
000179569 7001_ $$aRadujkovic, Aleksandar$$b9
000179569 7001_ $$aSchmitt, Michael$$b10
000179569 7001_ $$0P:(DE-He78)e15dfa1260625c69d6690a197392a994$$aBenner, Axel$$b11$$eLast author$$udkfz
000179569 77318 $$2Crossref$$3journal-article$$a10.1007/s00134-022-06676-3$$bSpringer Science and Business Media LLC$$d2022-04-16$$n6$$p753-755$$tIntensive Care Medicine$$v48$$x0342-4642$$y2022
000179569 773__ $$0PERI:(DE-600)1459201-0$$a10.1007/s00134-022-06676-3$$n6$$p753-755$$tIntensive care medicine$$v48$$x0342-4642$$y2022
000179569 909CO $$ooai:inrepo02.dkfz.de:179569$$pVDB
000179569 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0d054b6843ace36d1c965b6cb938d1c9$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000179569 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e15dfa1260625c69d6690a197392a994$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000179569 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000179569 9141_ $$y2022
000179569 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINTENS CARE MED : 2015
000179569 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000179569 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000179569 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000179569 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000179569 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000179569 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000179569 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000179569 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000179569 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000179569 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000179569 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bINTENS CARE MED : 2015
000179569 9202_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x0
000179569 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x0
000179569 980__ $$ajournal
000179569 980__ $$aVDB
000179569 980__ $$aI:(DE-He78)C060-20160331
000179569 980__ $$aUNRESTRICTED
000179569 999C5 $$1T Luft$$2Crossref$$9-- missing cx lookup --$$a10.1016/S2352-3026(17)30108-4$$pe414 -$$tLancet Haematol$$uLuft T, Benner A, Jodele S et al (2017) EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis. Lancet Haematol 4(9):e414–e423$$v4$$y2017
000179569 999C5 $$1M Pena$$2Crossref$$9-- missing cx lookup --$$a10.1182/bloodadvances.2021004812$$p3418 -$$tBlood Adv$$uPena M, Salas MQ, Mussetti A et al (2021) Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation. Blood Adv 5(17):3418–3426$$v5$$y2021
000179569 999C5 $$1A Varma$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.bbmt.2020.01.028$$p1013 -$$tBiol Blood Marrow Transplant$$uVarma A, Rondon G, Srour SA et al (2020) Endothelial Activation and Stress Index (EASIX) at admission predicts fluid overload in recipients of allogeneic stem cell transplantation. Biol Blood Marrow Transplant 26:1013$$v26$$y2020
000179569 999C5 $$1T Luft$$2Crossref$$9-- missing cx lookup --$$a10.3389/fimmu.2021.634416$$p634416 -$$tFront Immunol$$uLuft T, Wendtner CM, Kosely F et al (2021) EASIX for prediction of outcome in hospitalized SARS-CoV-2 infected patients. Front Immunol 12:634416$$v12$$y2021
000179569 999C5 $$1M Pennisi$$2Crossref$$9-- missing cx lookup --$$a10.1182/bloodadvances.2020003885$$p3397 -$$tBlood Adv$$uPennisi M, Sanchez-Escamilla M, Flynn JR et al (2021) Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells. Blood Adv 5(17):3397–3406$$v5$$y2021